Careplus Medical Prosthetic/Orthotic Supplier Location: 5602 Oakham Pl, Centreville, Virginia 20120 Phone: (571) 318-9711 |
Giant Pharmacy #740 Durable Medical Equipment & Medical Supplies Location: 5615 Stone Rd, Centreville, Virginia 20120 Phone: (703) 803-8556 |
Giant Pharmacy #788 Durable Medical Equipment & Medical Supplies Location: 14125 Saint Germain Dr, Centreville, Virginia 20121 Phone: (703) 631-7720 |
Cvs Pharmacy #01416 Durable Medical Equipment & Medical Supplies Location: 5652 Pickwick Rd, Centreville, Virginia 20120 Phone: (703) 631-9440 |
Walgreens #10331 Durable Medical Equipment & Medical Supplies Location: 13926 Lee Hwy, Centreville, Virginia 20120 Phone: (703) 259-6200 |
News Archive
A vaccine that protects against a wide variety of influenza viruses (a so-called universal flu vaccine) is a critical public health goal given the significant rates of illness and death caused by seasonal influenza and the potentially devastating effects of a pandemic influenza strain.
Fujitsu Laboratories Ltd. announced the development of a technology that accelerates database analyses of the correlations between genomic variations and environmental information, such as disease and lifestyle habits. This technology speeds up the process by a factor of roughly 400 compared to existing methods.
Researchers have found a way to help make chemotherapy more effective in treating colon cancer. They identified a new pathway (RICTOR/mTORC2) as a biological target for the disease.
XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that eight presentations reporting on the Company's progress in diverse cancer therapy product candidates will be given at the 101st Annual Meeting of the American Association for Cancer Research, April 17 – 21, 2010, in Washington, DC.
› Verified 5 days ago